Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Related Posts North American Mining Conferences Presentation September 9, 2025 JLL Signs Non-Binding LOI to List McDermitt on a US Exchange September 9, 2025 Fortune Bay: Maximizing Shareholder Value in Gold and Uranium September 9, 2025